Cortrosyn Injection, Powder, Lyophilized, For Solution
Product Images NDC 71872-7318

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cortrosyn (NDC 71872-7318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7318.pdp (7318)

7318.pdp (7318)
Label for Cortrosyn (cosyntropin) injection powder, lyophilized, for solution, 0.25 mg per vial. Intended for intramuscular or intravenous use. The vial contains cosyntropin 0.25 mg and mannitol 10 mg. Manufactured by Amphastar Pharmaceuticals, repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ.*
FDA Label Image

Amino Acids (Amino)

Amino Acids (Amino)
Chemical structure diagram showing the amino acid sequence of a peptide, likely representing the primary structure of cosyntropin (Cortrosyn). The sequence lists amino acids by their three-letter codes arranged by position number from 1 to 24.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.